Understanding how lipids interact with membrane proteins
Unravelling Membrane Protein-Lipid Interactions using Nanodiscs and Mass Spectrometry
This study is looking at how fats in our cells interact with proteins that are important for health and disease, which could help scientists find better ways to develop drugs that target these proteins for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-10871807 on NIH RePORTER |
What this research studies
This research investigates the interactions between membrane proteins and lipids, which are crucial for many cellular functions and drug targeting. By using advanced techniques like mass spectrometry and nanodiscs, the study aims to identify which lipids bind to specific membrane proteins and how these interactions influence protein structure and function. This could help clarify the role of lipids in various diseases and improve drug development strategies. Patients may benefit from insights gained about how to better target drugs to membrane proteins involved in their conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that involve membrane protein dysfunction, such as certain genetic disorders or diseases related to ion channels.
Not a fit: Patients with conditions unrelated to membrane proteins or lipid interactions may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved drug targeting strategies for a variety of diseases.
How similar studies have performed: Other research has shown success in understanding protein-lipid interactions, but this approach using nanodiscs and mass spectrometry is relatively novel.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Marty, Michael T — University of Arizona
- Study coordinator: Marty, Michael T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.